FDA warns India’s Alchymars ICM SM Private Limited about CGMP deviations in its production of active pharmaceutical ingredients.
FDA warns Japan’s Sato Pharmaceutical Co. about CGMP violations in its production of finished over-the-counter drugs.
FDA warns India’s Alchymars ICM SM Private Limited about CGMP deviations in its production of active pharmaceutical ingredients.
FDA warns Japan’s Sato Pharmaceutical Co. about CGMP violations in its production of finished over-the-counter drugs.
The U.S. government urges the Supreme Court to reject an appeal by a Texas compounding pharmacy in a closely watched case over whether federal drug law preempts state-law claims challenging the sale of compounded drugs.
Outlook Therapeutics wins an appeal with FDA over its BLA for ONS-5010/Lytenava (bevacizumab-vikg), clearing a potential path toward U.S. approval of the investigational wet age-related macular degeneration treatment.
